Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trial
10.1093/eurheartj/ehad543
Saved in:
Main Authors: | Dalakoti, Mayank, Foo, Roger |
---|---|
Other Authors: | MEDICINE |
Format: | Editorial |
Language: | English |
Published: |
OXFORD UNIV PRESS
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic
by: Yeo, Tee Joo, et al.
Published: (2021) -
Stress Cardiomyopathy with Transient Biventricular Dysfunction Following Recent COVID-19 Infection
by: Koh, Matthew CY, et al.
Published: (2021) -
PULSED ELECTROMAGNETIC FIELD STIMULATION AS A POTENTIAL CARDIOPROTECTIVE INTERVENTION
by: Purnamawati, K, et al.
Published: (2020) -
Underlying Differences in the Treatment of Left Ventricular Thrombus With Non-Vitamin K Antagonist Oral Anticoagulants
by: Leow, Aloysius Sheng-Ting, et al.
Published: (2021) -
Surprisingly low incidence of left ventricular thrombosis in anterior ST-segment elevation myocardial infarction
by: Leow, Aloysius Sheng-Ting, et al.
Published: (2021)